UCB And 4 Other Stocks Have Very High Payout Ratio

(VIANEWS) – NOVABASE,SGPS (NBA.LS), GOLDEN OCEAN GROUP (GOGL.OL), UCB (UCB.BR) are the highest payout ratio stocks on this list.

We have collected information regarding stocks with the highest payout ratio up until now. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.

1. NOVABASE,SGPS (NBA.LS)

195.45% Payout Ratio

Novabase S.G.P.S., S.A., through its subsidiaries, provides IT consulting and services in Portugal, Europe, Africa, the Middle East, and internationally. It operates through two segments, Next-Gen and Value Portfolio. The Next-Gen segment develops IT consulting and services to banks, insurance, capital markets, and telecommunication sectors. This segment operates under the Celfocus brand name. The Value Portfolio segment operates and develops IT consulting, staffing, and services under the Neotalent brand. This segment involves in venture capital activities. Novabase S.G.P.S., S.A. was incorporated in 1989 and is headquartered in Lisbon, Portugal.

Earnings Per Share

As for profitability, NOVABASE,SGPS has a trailing twelve months EPS of €0.11.

PE Ratio

NOVABASE,SGPS has a trailing twelve months price to earnings ratio of 57.45. Meaning, the purchaser of the share is investing €57.45 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.03%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Jun 21, 2023, the estimated forward annual dividend rate is 0.1 and the estimated forward annual dividend yield is 2.26%.

Volume

Today’s last reported volume for NOVABASE,SGPS is 3294 which is 8.78% above its average volume of 3028.

Revenue Growth

Year-on-year quarterly revenue growth grew by 16.9%, now sitting on 176.23M for the twelve trailing months.

More news about NOVABASE,SGPS.

2. GOLDEN OCEAN GROUP (GOGL.OL)

89.29% Payout Ratio

Golden Ocean Group Limited, a shipping company, owns and operates a fleet of dry bulk vessels worldwide. It operates dry bulk vessels comprising of Newcastlemax, Capesize, Panamax, and Ultramax vessels in the spot and time charter markets. The company's vessels transport a range of bulk commodities, such as ores, coal, grains, and fertilizers. As of March 16, 2023, it owned a fleet of 74 dry bulk vessels. The company is based in Hamilton, Bermuda.

Earnings Per Share

As for profitability, GOLDEN OCEAN GROUP has a trailing twelve months EPS of kr5.87.

PE Ratio

GOLDEN OCEAN GROUP has a trailing twelve months price to earnings ratio of 24.28. Meaning, the purchaser of the share is investing kr24.28 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.85%.

More news about GOLDEN OCEAN GROUP.

3. UCB (UCB.BR)

75.57% Payout Ratio

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx for treating plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis; and Fintepla to treat Dravet syndrome. In addition, the company is involved in developing rozanolixizumab and Zilbrisq to treat myasthenia gravis; dapirolizumab pegol for systemic lupus erythematosus; fenfluramine to treat CDKL5 deficiency disorder; doxecitine for TK2 deficiency disorder; STACCATO alprazolam for stereotypical prolonged seizures; bepranemab to treat Alzheimer's disease; minzasolmin and UCB0222 for Parkinson's disease; and UCB1381 and UCB9741 for atropic dermatitis. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, and Otsuka. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.

Earnings Per Share

As for profitability, UCB has a trailing twelve months EPS of €1.76.

PE Ratio

UCB has a trailing twelve months price to earnings ratio of 61.53. Meaning, the purchaser of the share is investing €61.53 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.8%.

Sales Growth

UCB’s sales growth for the current quarter is 6.5%.

Yearly Top and Bottom Value

UCB’s stock is valued at €108.30 at 11:10 EST, under its 52-week high of €110.10 and way higher than its 52-week low of €65.40.

More news about UCB.

4. UMICORE (UMI.BR)

50% Payout Ratio

Umicore SA operates as a materials technology and recycling company worldwide. It operates through Catalysis, Energy & Surface Technologies, and Recycling segments. The Catalysis segment produces automotive catalysts for gasoline, and diesel light and heavy-duty diesel applications; stationary catalysis for industrial emissions control; and precious metals-based compounds and catalysts for use in the pharmaceutical and fine chemicals industries, as well as fuel cell applications. The Energy & Surface Technologies segment offers cobalt and specialty materials, rechargeable battery materials, and electro-optic materials, as well as metal deposition solutions, including electroplating and PVD coating. The Recycling segment treats waste streams containing precious and other specialty metals from a range of industrial residues and end-of-life materials. This segment also produces precious metals-based materials for glass production, electric, and electronic applications. The company was formerly known as Union Minière du Haut Katanga and changed its name to Umicore SA in 2001. Umicore SA was founded in 1805 and is headquartered in Brussels, Belgium.

Earnings Per Share

As for profitability, UMICORE has a trailing twelve months EPS of €1.6.

PE Ratio

UMICORE has a trailing twelve months price to earnings ratio of 12.85. Meaning, the purchaser of the share is investing €12.85 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.38%.

Sales Growth

UMICORE’s sales growth for the current quarter is 6.9%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Apr 29, 2024, the estimated forward annual dividend rate is 1.1 and the estimated forward annual dividend yield is 5.39%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 28.9%, now sitting on 18.27B for the twelve trailing months.

Moving Average

UMICORE’s value is below its 50-day moving average of €21.10 and way under its 200-day moving average of €23.65.

More news about UMICORE.

5. AALBERTS NV (AALB.AS)

38.95% Payout Ratio

Aalberts N.V. engineers mission-critical technologies. It operates in two segments: Building Technology and Industrial Technology. The Building Technology segment develops, manufactures, and monitors hydronic flow control systems for heating and cooling to enhance the energy efficiency; and develops, designs, and manufactures integrated piping systems to distribute and regulate water or gas flows in heating, cooling, water, gas, and sprinkler systems in eco-friendly buildings and industrial niches. The Industrial Technology segment co-develops, engineers, and manufactures advanced mechatronics and technologies to regulate, measure, and control fluids under severe and critical conditions for active OEMs in semicon efficiency, sustainable transportation, and industrial niches; and offers a range of surface technologies utilizing a network of service locations local knowledge to customers active in sustainable transportation and industrial niches. It operates in Western Europe, the United States, Russia, Eastern Europe, the Asia-Pacific, the Middle East, and Africa. The company was formerly known as Aalberts Industries N.V. and changed its name to Aalberts N.V. in April 2019. Aalberts N.V. was founded in 1975 and is headquartered in Utrecht, the Netherlands.

Earnings Per Share

As for profitability, AALBERTS NV has a trailing twelve months EPS of €2.85.

PE Ratio

AALBERTS NV has a trailing twelve months price to earnings ratio of 14.87. Meaning, the purchaser of the share is investing €14.87 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.14%.

Moving Average

AALBERTS NV’s worth is way above its 50-day moving average of €37.98 and way above its 200-day moving average of €37.10.

More news about AALBERTS NV.

1. 1 (1)

1% Payout Ratio

1

Earnings Per Share

As for profitability, 1 has a trailing twelve months EPS of €1.

PE Ratio

1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

1’s EBITDA is 1.

Sales Growth

1’s sales growth is 1% for the present quarter and 1% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, 1’s stock is considered to be overbought (>=80).

More news about 1.

Leave a Reply

Your email address will not be published. Required fields are marked *